Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 28, 2023

BUY
$0.56 - $0.8 $119 - $171
214 New
214 $0
Q2 2022

Jul 28, 2022

SELL
$0.57 - $1.0 $113 - $200
-200 Closed
0 $0
Q4 2021

Jan 31, 2022

SELL
$0.53 - $1.09 $53 - $109
-100 Reduced 33.33%
200 $0
Q1 2021

Sep 15, 2021

BUY
$1.56 - $2.7 $156 - $270
100 Added 50.0%
300 $0
Q1 2021

Apr 27, 2021

SELL
$1.56 - $2.7 $156 - $270
-100 Reduced 33.33%
200 $0
Q4 2020

Sep 15, 2021

BUY
$0.8 - $2.56 $80 - $256
100 Added 50.0%
300 $0
Q4 2020

Jan 27, 2021

SELL
$0.8 - $2.56 $80 - $256
-100 Reduced 33.33%
200 $0
Q3 2020

Sep 15, 2021

BUY
$0.79 - $1.52 $79 - $152
100 Added 50.0%
300 $0
Q3 2020

Oct 19, 2020

SELL
$0.79 - $1.52 $79 - $152
-100 Reduced 33.33%
200 $0
Q2 2020

Sep 15, 2021

SELL
$0.68 - $1.13 $3,345 - $5,559
-4,920 Reduced 94.25%
300 $0
Q2 2020

Jul 22, 2020

BUY
$0.68 - $1.13 $3,345 - $5,559
4,920 Added 1640.0%
5,220 $5,000
Q1 2020

Sep 15, 2021

SELL
$0.78 - $1.95 $3,837 - $9,594
-4,920 Reduced 94.25%
300 $0
Q1 2020

Apr 28, 2020

BUY
$0.78 - $1.95 $3,837 - $9,594
4,920 Added 1640.0%
5,220 $5,000
Q4 2019

Sep 14, 2021

SELL
$1.25 - $1.82 $5,900 - $8,590
-4,720 Reduced 94.02%
300 $0
Q4 2019

Jan 27, 2020

BUY
$1.25 - $1.82 $5,900 - $8,590
4,720 Added 1573.33%
5,020 $9,000
Q3 2019

Sep 14, 2021

SELL
$1.96 - $3.38 $9,251 - $15,953
-4,720 Reduced 94.02%
300 $0
Q3 2019

Oct 22, 2019

BUY
$1.96 - $3.38 $9,251 - $15,953
4,720 Added 1573.33%
5,020 $10,000
Q2 2019

Sep 14, 2021

SELL
$2.58 - $4.92 $7,017 - $13,382
-2,720 Reduced 90.07%
300 $0
Q2 2019

Jul 31, 2019

BUY
$2.58 - $4.92 $7,017 - $13,382
2,720 Added 906.67%
3,020 $11,000
Q1 2019

Sep 02, 2021

SELL
$3.0 - $4.85 $3,660 - $5,917
-1,220 Reduced 80.26%
300 $0
Q4 2018

Jan 25, 2019

BUY
$2.49 - $5.5 $3,784 - $8,360
1,520 New
1,520 $5,000

Others Institutions Holding AGE

# of Institutions
1
Shares Held
1K
Call Options Held
0
Put Options Held
0

About AgeX Therapeutics, Inc.


  • Ticker AGE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 37,945,100
  • Description
  • AgeX Therapeutics, Inc., a biotechnology company, focuses on the development and commercialization of novel therapeutics targeting human aging and degenerative diseases in the United States. The company's lead cell-based therapeutic candidates in development include AGEX-BAT1, a cell therapy product candidate for the treatment of various age-rel...
More about AGE
Track This Portfolio

Track Cwm, LLC Portfolio

Follow Cwm, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cwm, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cwm, LLC with notifications on news.